Literature DB >> 15236315

Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma.

Shalini C Reshmi1, William S Saunders, Donna M Kudla, Camille Rose Ragin, Susanne M Gollin.   

Abstract

Squamous cell carcinoma of the head and neck and its subset, oral squamous cell carcinoma (OSCC), arise through a multistep process of genetic alterations as a result of exposure to environmental agents, such as tobacco smoke, alcoholic beverages, and viruses, including human papillomavirus. We and others have shown that the karyotypes of OSCC are near-triploid and contain multiple structural and numerical abnormalities. However, despite a background of clonal chromosomal aberrations, individual cells within a culture express many nonclonal numerical and structural abnormalities, termed chromosomal instability (CIN). To evaluate CIN in oral cancer cells, we isolated clones from two OSCC cell lines and carried out classical cytogenetic analysis, fluorescence in situ hybridization using centromere-specific probes, and spectral karyotyping. We observed variation in chromosome number within clones and between clones of the same cell line. Although similar numbers of centromeric signals for a particular chromosome were present, "homologs" of a chromosome varied structurally from cell to cell (marker chromosome evolution) as documented by classical and spectral karyotyping. In addition to the numerical chromosome variations within a clone, we observed marker chromosome evolution by structural chromosome alterations. It appears that both intrinsic structural alterations and extrinsic cytoskeletal factors influence chromosome segregation, resulting in individual tumor cells that express unique karyotypes. We show that CIN and marker chromosome evolution are essential acquired features of neoplastic cells. Proliferation of this heterogeneous cell population may provide some cells with the ability to evade standard therapies. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236315     DOI: 10.1002/gcc.20064

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.

Authors:  Jason S White; Joel L Weissfeld; Camille C R Ragin; Karen M Rossie; Christa Lese Martin; Michele Shuster; Chandramohan S Ishwad; John C Law; Eugene N Myers; Jonas T Johnson; Susanne M Gollin
Journal:  Oral Oncol       Date:  2006-11-16       Impact factor: 5.337

2.  Amplification of the chromosome 20q region is associated with expression of HPV-16 E7 in human airway and anogenital epithelial cells.

Authors:  Aloysius J Klingelhutz; Qining Qian; Stacia L Phillips; Francoise A Gourronc; Benjamin W Darbro; Shivanand R Patil
Journal:  Virology       Date:  2005-09-30       Impact factor: 3.616

3.  The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma.

Authors:  Shamini Selvarajah; Maisa Yoshimoto; Paul C Park; Georges Maire; Jana Paderova; Jane Bayani; Gloria Lim; Khaldoun Al-Romaih; Jeremy A Squire; Maria Zielenska
Journal:  Chromosoma       Date:  2006-08-09       Impact factor: 4.316

4.  Establishment and characterization of an HPV16 E6/E7-expressing oral squamous cell carcinoma cell line with enhanced tumorigenicity.

Authors:  Dongxia Ye; Xiaojian Zhou; Hongya Pan; Qian Jiang; Laiping Zhong; Wantao Chen; Zhiyuan Zhang
Journal:  Med Oncol       Date:  2010-05-13       Impact factor: 3.064

5.  Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.

Authors:  Hatem O Kaseb; Helene Fohrer-Ting; Dale W Lewis; Eric Lagasse; Susanne M Gollin
Journal:  Exp Cell Res       Date:  2016-09-09       Impact factor: 3.905

Review 6.  Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.

Authors:  Christa Lese Martin; Shalini C Reshmi; Thomas Ried; William Gottberg; John W Wilson; Jaya K Reddy; Poornima Khanna; Jonas T Johnson; Eugene N Myers; Susanne M Gollin
Journal:  Oral Oncol       Date:  2007-08-02       Impact factor: 5.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.